LiraglutideCheck methods and identity
Why a type 1 diabetes study measured C-peptide
2 numbered sourcesSource years 2025, 2026
A peptide is a short amino-acid chain whose links are peptide bonds. Some peptides act as signals, while others can be measured as clues to what a cell produces. Liraglutide is a modified GLP-1 receptor agonist peptide. Its effects on blood glucose in type 2 diabetes led researchers to ask a narrower question in people with long-standing type 1 diabetes. Could the medicine preserve any insulin-making function that remained? [1, 2]
When pancreatic beta cells make insulin, they split a precursor into insulin and a separate short chain called C-peptide. A C-peptide measurement can help researchers estimate how much insulin the body is making itself. The study enrolled 18 adults with type 1 diabetes who still had measurable fasting C-peptide. They were randomly assigned to liraglutide or placebo for 52 weeks. The investigators measured C-peptide after a standardized meal to see how the remaining beta cells responded to food. [1]
The primary outcome compared the change in stimulated C-peptide at week 52. The researchers did not find that liraglutide improved that outcome compared with placebo. They also examined results across several visits, including a visit after treatment ended, in an exploratory analysis. In that analysis C-peptide fell more steeply in the liraglutide group. Because the latter analysis was exploratory and the trial was very small, it provides a question for further study rather than a precise estimate of harm. [1]
This trial concerns residual beta-cell function in adults with long-standing type 1 diabetes. The U.S. Victoza label describes a type 2 diabetes indication for glycemic control. The groups and the biological questions differ. A change in HbA1c in type 2 diabetes would not tell researchers how much insulin a person with type 1 diabetes can still produce. By measuring C-peptide after a meal, the investigators directly tested the particular question that motivated their trial. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
